Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 May 2016
At a glance
- Drugs Tofacitinib (Primary)
- Indications Alopecia areata
- Focus Therapeutic Use
- 26 Apr 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.
- 08 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 12 Dec 2014 New trial record